Little information is available publicly on invasive meningococcal disease (IMD) in elderly people in Australia. This study analysed IMD notifications data from New South Wales between 1993 and 2012 to determine the distribution of IMD among people aged 65 years and older and to describe the characteristics of IMD in this age group compared to younger age groups with respect to notification trends, serogroup distribution and mortality rates. Following introduction of a childhood vaccination programme against meningococcal type C in 2003, notification rates in all age groups decreased, but the proportion of IMD notifications in people aged 65 years and over rose significantly (from 4% to 6%, P = 0.01). Mortality rates from IMD in those aged 65 years and older were significantly higher than overall rates (32% compared to 5%, P < 0.01). Serogroup Y accounted for 23% of infections in the elderly compared to 3% in people aged under 65 years (P < 0.01). As the population ages, the elderly may account for a higher number of IMD cases in Australia. Protocols at the state and national level should be updated to provide guidance on the clinical and public health management of elderly people with IMD.
I
nvasive disease caused by Neisseria meningitidis occurs when bacteria enter a normally sterile site such as blood (causing septicaemia) or cerebrospinal fluid (causing meningitis).
1 Transmission is by respiratory droplets and up to 10% of the population may harbour Neisseria meningitidis in their nasopharynx without disease. 1 Asymptomatic carriage is higher in household contacts of patients with meningococcal disease (12.4%).
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In Australia, the highest rates of invasive meningococcal disease (IMD) are among children under 5 years and young adults between 15 and 24 years of age. 
RESULTS

Notifi cations by age group
Between 1993 and 2012, there were 2995 notifications of IMD in NSW. Annual notifications peaked at 253 in 2000, decreasing to 66 in 2012 (Figure 1) . The age group with the highest number of notifications each year was 0-14 year olds; the lowest was observed for the 65 years and over age group (Figure 1) .
Over the 20-year period, there were 153 notifications (5.1%) in those aged 65 years and over. The Health District in northern NSW was notified of a case of IMD in a resident of an aged care facility. The response to this case revealed a lack of published guidance with respect to the public health management of IMD in the elderly, particularly in the definition of close contacts and administration of clearance treatment.
The aim of the current epidemiological investigation was to examine IMD trends in NSW with a particular focus on the proportion of notifications in people aged 65 years and over, mortality rates and serogroup distribution. Implications for the prevention and management of IMD are also discussed.
METHODS
IMD notification data for the period 1993 to 2012 for NSW were sourced from the NSW Ministry of Health. Analysis was performed using Microsoft Excel, Statistical Analysis Software (SAS) Enterprise Guide 5.1 (SAS Institute Inc. Seattle, WA, USA) and STATA 11 (Stata Corp. 2009, College Station, TX, USA). IMD notification rates were calculated using mid-year NSW population data from the Australian Bureau of Statistics and proportions were compared using the chi-squared ( 2 ) test.
Annualized notification rates by age groups An increase in the proportion of IMD due to serogroup Y has occurred in NSW during the past 10 years. This has been previously reported throughout Australia, although statistical significance was not demonstrated.
8
Research in the United States of America and United Kingdom has also found a higher prevalence of serogroup Y in older people.
9,10 Higher CFRs have previously been reported in older people with IMD (particularly among those with underlying medical conditions) and among serogroup Y cases even after controlling for age.
9-11
This may explain the higher CFR in older persons in this study; they had a higher proportion of infection with serogroup Y.
Potential increases in the number of IMD cases among the elderly, as a result of an ageing population, have implications not only for the clinical management of these cases but also for the public health response. The current Guidelines for the early clinical and public health management of meningococcal disease in Australia recommend provision of clearance antibiotics to household contacts or household-like contacts in was a gradual reduction in the proportion of infections caused by serogroup C and an increase primarily in the proportion caused by serogroup B (Figure 2) .
Of the 64 notifications in those aged 65 years and older, 30 (47%) were serogroup B, 10 (16%) were serogroup C, 15 (23%) were serogroup Y and 9 were (14%) serogroup W. For those under 65 years of age, 602 (77%) were serogroup B, 125 (16%) were serogroup C, 21 (3%) were serogroup Y and 35 (4%) were serogroup W. The difference in proportions attributable to serogroup Y infection between the two age groups was statistically significant (P < 0.01). 
DISCUSSION
The absolute number of IMD cases in NSW residents aged 65 years and over has remained low over the past 20 years, and rates for all age groups have decreased, -care setting and be tested and notified by a treating physician, thus the notification data should approximate incidence.
CONCLUSION
The epidemiology of IMD in NSW, Australia has changed following the introduction of the childhood vaccination programmes, with a higher proportion of infections in those aged 65 years and over attributable to serogroup Y. Similar analysis should be conducted at the national and regional levels to determine whether similar trends are occurring across Australia and other countries that have introduced childhood meningococcal C vaccination programmes. As the Australian population is ageing, there may be increases in the number of notifications of IMD among people aged 65 years and over, including cases and potentially outbreaks in aged care facilities. Such an increase would have serious implications given the higher mortality rates in this group. National protocols should be updated to provide clinical and public health guidance for this age group.
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A similar lack of specificity is also found in other national and regional guidelines ( Table 2 ) with no particular guidelines on meningococcal disease available for the Western Pacific Region.
Outbreaks in residential aged care facilities have been reported, but specific studies are limited and provide contradictory advice. 13 Prophylaxis was administered following a case of meningococcal disease in an aged care facility in the United States of America in 1997; a further case was then reported in a patient who had refused prophylaxis. 14 A carriage study in the United Kingdom conducted after a case of meningococcal disease was diagnosed in a nursing home conversely found that no residents or caregivers had the same serosubtype of Neisseria meningitidis as the index case, and the study concluded that prophylaxis was not necessary in such settings.
15
The analyses on serogroup and mortality presented in this study should be interpreted with caution given the amount of missing information, particularly between 1993 and 2002 and because the estimates among older people are based on relatively small numbers. It is also likely that mortality was underestimated across all age groups, given the difficulty in determining a single cause of death. However, as IMD is a notifiable and serious disease, affected patients are likely to present in a health 
